Review



block balanced randomisation codes  (Catalent Pharma Solutions)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Catalent Pharma Solutions block balanced randomisation codes
    Block Balanced Randomisation Codes, supplied by Catalent Pharma Solutions, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/balanced+block+randomisation/block+balanced+randomisation+codes/pmc06537970__bmjopen___2019___029554__draft_revisions-706-32-43
    Average 90 stars, based on 1 article reviews
    block balanced randomisation codes - by Bioz Stars, 2026-09
    90/100 stars

    Images

    Related Articles

    Sequencing:

    Article Title: Creation of a database to assess effects of omega-3, omega-6 and total polyunsaturated fats on health: methodology for a set of systematic reviews
    Article Snippet: Allocation concealment (selection bias) Low risk Patients were randomly assigned by the investigator in each site by allocation of a pre numbered treatment pack (block balanced randomisation codes were computer generated by Catalent Pharma Solutions, Bolton, UK).

    Article Title: Creation of a database to assess effects of omega-3, omega-6 and total polyunsaturated fats on health: methodology for a set of systematic reviews
    Article Snippet: Risk of bias table Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Patients were randomly assigned by the investigator in each site by allocation of a pre numbered treatment pack (block balanced randomisation codes were computer generated by Catalent Pharma Solutions, Bolton, UK).

    Selection:

    Article Title: Creation of a database to assess effects of omega-3, omega-6 and total polyunsaturated fats on health: methodology for a set of systematic reviews
    Article Snippet: Allocation concealment (selection bias) Low risk Patients were randomly assigned by the investigator in each site by allocation of a pre numbered treatment pack (block balanced randomisation codes were computer generated by Catalent Pharma Solutions, Bolton, UK).

    Article Title: Creation of a database to assess effects of omega-3, omega-6 and total polyunsaturated fats on health: methodology for a set of systematic reviews
    Article Snippet: Risk of bias table Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Patients were randomly assigned by the investigator in each site by allocation of a pre numbered treatment pack (block balanced randomisation codes were computer generated by Catalent Pharma Solutions, Bolton, UK).

    Blocking Assay:

    Article Title: Creation of a database to assess effects of omega-3, omega-6 and total polyunsaturated fats on health: methodology for a set of systematic reviews
    Article Snippet: Allocation concealment (selection bias) Low risk Patients were randomly assigned by the investigator in each site by allocation of a pre numbered treatment pack (block balanced randomisation codes were computer generated by Catalent Pharma Solutions, Bolton, UK).

    Article Title: Creation of a database to assess effects of omega-3, omega-6 and total polyunsaturated fats on health: methodology for a set of systematic reviews
    Article Snippet: Risk of bias table Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Patients were randomly assigned by the investigator in each site by allocation of a pre numbered treatment pack (block balanced randomisation codes were computer generated by Catalent Pharma Solutions, Bolton, UK).

    Generated:

    Article Title: Creation of a database to assess effects of omega-3, omega-6 and total polyunsaturated fats on health: methodology for a set of systematic reviews
    Article Snippet: Allocation concealment (selection bias) Low risk Patients were randomly assigned by the investigator in each site by allocation of a pre numbered treatment pack (block balanced randomisation codes were computer generated by Catalent Pharma Solutions, Bolton, UK).

    Article Title: Creation of a database to assess effects of omega-3, omega-6 and total polyunsaturated fats on health: methodology for a set of systematic reviews
    Article Snippet: Risk of bias table Bias Authors' judgement Support for judgement Random sequence generation (selection bias) Low risk Patients were randomly assigned by the investigator in each site by allocation of a pre numbered treatment pack (block balanced randomisation codes were computer generated by Catalent Pharma Solutions, Bolton, UK).



    Similar Products

    block-balanced randomisation  (StatsDirect ltd)
    90
    StatsDirect ltd block-balanced randomisation
    Block Balanced Randomisation, supplied by StatsDirect ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/balanced+block+randomisation/block+balanced+randomisation/pmc06429886-59-1-10
    Average 90 stars, based on 1 article reviews
    block-balanced randomisation - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    block balanced randomisation codes  (Catalent Pharma Solutions)
    90
    Catalent Pharma Solutions block balanced randomisation codes
    Block Balanced Randomisation Codes, supplied by Catalent Pharma Solutions, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/balanced+block+randomisation/block+balanced+randomisation+codes/pmc06537970__bmjopen___2019___029554__draft_revisions-706-32-43
    Average 90 stars, based on 1 article reviews
    block balanced randomisation codes - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    balanced block randomisation scheme  (Bilcare Inc)
    90
    Bilcare Inc balanced block randomisation scheme
    Balanced Block Randomisation Scheme, supplied by Bilcare Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/balanced+block+randomisation/balanced+block+randomisation+scheme/pm27109816-64-11-17
    Average 90 stars, based on 1 article reviews
    balanced block randomisation scheme - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier
    balanced block randomisation  (Tillotts Pharma AG)
    90
    Tillotts Pharma AG balanced block randomisation
    Characteristics of included studies [ordered by study ID]
    Balanced Block Randomisation, supplied by Tillotts Pharma AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/balanced+block+randomisation/balanced+block+randomisation/pmc04170890-309-2-8
    Average 90 stars, based on 1 article reviews
    balanced block randomisation - by Bioz Stars, 2026-09
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Characteristics of included studies [ordered by study ID]

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet: Characteristics of included studies [ordered by study ID]

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Blocking Assay, Control, Activity Assay

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules, Clinical Proteomics

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Blocking Assay, Control, Capsules, Labeling

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Generated, Control

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Blocking Assay, Control

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Sequencing, Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Generated, Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Generated, Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules, Membrane

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Membrane, Activity Assay

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Capsules, Control, Clinical Proteomics

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Generated, Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Software, Control, Capsules, Membrane

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Software, Control, Capsules, Membrane

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules, Clinical Proteomics

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules, Clinical Proteomics

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Blocking Assay, Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Capsules, Control

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Generated, Produced, Filtration, Control, Emulsion

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Clinical Proteomics

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Selection, Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Labeling, Capsules, Control, Clinical Proteomics

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules, Clinical Proteomics

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules, Clinical Proteomics

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Generated, Sequencing, Control, Capsules

    Journal: The Cochrane database of systematic reviews

    Article Title: Omega 3 fatty acids for prevention and treatment of cardiovascular disease

    doi: 10.1002/14651858.CD003177.pub2

    Figure Lengend Snippet:

    Article Snippet: Methods , Randomisation: balanced block randomisation performed by Tillotts Pharma Allocation concealment: Done Participants masked: yes Providers masked: yes Outcome assessors masked: yes Summary risk of bias: low , .

    Techniques: Clinical Proteomics, Control